Obsessive Compulsive Disorder (OCD)
Clinical Trial

MAC Clinical Research is testing a new medication for OCD.

Improving quality of life

Key Information


£490 plus reasonable travel costs

Gender and Age

Males and Females aged 18 - 65

Key Requirements

- OCD symptoms or diagnosis for at least 1 year
- Taking an antidepressant that isn’t fully helping


Lancashire, Merseyside, South Staffordshire,
South Yorkshire, Teesside and West Yorkshire

Health Check

Receive a free comprehensive health check

Register Your Interest

Data Privacy Statement
“We're very excited to be conducting research into obsessive compulsive disorder. Recent studies have suggested that this study drug will inhibit signalling pathways in the brain that are important in obsessive or compulsive behaviours. With your participation, you may be able to contribute to scientific research which may lead to a new medicine to help people suffering from OCD."
Dr Aliya Asher
Principal Investigator

What Happens Next?

What happens next?

1. Sign Up

Register your interest on our website or over the phone

2. We'll Call You

Our study specialists will call you to discuss your health and check if the trial is suitable for you

3. Eligible?

If eligible, you will be booked in for a 'CHAT' where you'll receive a Patient Information Sheet (PIS)

4. Medical History

If you decide to take part, our medical team will obtain a copy of your medical history from your GP

5. Health Check

You will attend a free comprehensive health check with a MAC doctor and your eligibility will be confirmed

6. Enrollment

You will be enrolled onto the clinical trial and attend scheduled visits (Travel expenses or transport to clinic provided)

About This OCD Clinical Trial

People with OCD tend to have signalling pathways in the brain which are overactive, called the glutamatergic pathways. The drug used in the study, troriluzole, works to dampen down these overactive pathways (called the glutamatergic signalling pathway) which may help people with OCD when used in combination with your usual OCD medication.

Would you like to keep up to date with clinical research opportunities?